Stockscreener 앱 받기
8.25
0.96%
-0.08
시간 외 거래:
8.25
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
Fennec Pharmaceuticals to Announce Q2 2025 Financial Results - TipRanks
Why Fennec Pharmaceuticals Inc. is moving todayShort-Term Bounce Forecast for Oversold Stocks - Newser
Fennec Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 14, 2025 - The Manila Times
Fennec Pharmaceuticals to announce Q2 2025 financial results on Aug. 14. - AInvest
Fennec Pharmaceuticals Sets Q2 Earnings Date: Specialty Pharma Company to Update Investors August 14 - Stock Titan
Can trapped investors hope for a rebound in Fennec Pharmaceuticals Inc.Entry Signal Generator with Risk Metrics - Newser
Fennec Pharmaceuticals Inc. stock outlook for YEAREarly Entry Ideas with Momentum Potential - Newser
Measuring Fennec Pharmaceuticals Inc.’s beta against major indicesBuy Alert Based on RSI and Volume - Newser
Real time pattern detection on Fennec Pharmaceuticals Inc. stockDividend Strategy Summary With 10-Year Outlook - Newser
Will Fennec Pharmaceuticals Inc. stock go up soonFree Opportunity Map for Daily Stock Trading - Newser
Adherex Technologies (FENC) to Release Earnings on Tuesday - Defense World
What makes Fennec Pharmaceuticals Inc. stock price move sharplyShort-Term Swing Opportunity Summary Sheet - Newser
How to interpret RSI for Fennec Pharmaceuticals Inc. stockPredictive System for Long-Term Stock Forecast - Newser
Fennec Pharmaceuticals FENC Q2 2025 Earnings Preview Downside Concerns Amid Product Vulnerability Issues - AInvest
How Fennec Pharmaceuticals Inc. stock performs during market volatilityLong-Term Signal Tracking and Profit Summary - Newser
Full technical analysis of Fennec Pharmaceuticals Inc. stockPredictive Model for Intraday Swing Forecast - Newser
Anterix Holds Virtual Annual Stockholders Meeting - The Globe and Mail
How to manage a losing position in Fennec Pharmaceuticals Inc.Free Portfolio Diversification Stock Ideas - Newser
Using data filters to optimize entry into Fennec Pharmaceuticals Inc.Rapid Trade Forecast Based on Indicators - Newser
Evaluating Fennec Pharmaceuticals Inc. with trendline analysisCapital Protection Strategy With Risk Analysis - Newser
Adherex Technologies (NASDAQ:FENC) Trading Up 6.1% – Still a Buy? - Defense World
Is it too late to sell Fennec Pharmaceuticals Inc.Summary of Long-Term Buy Zone Stocks - Newser
Why Fennec Pharmaceuticals Inc. stock attracts strong analyst attentionEntry Signal Generator with Risk Metrics - Newser
Using economic indicators to assess Fennec Pharmaceuticals Inc. potentialFree Early Entry Tips With Low Risk Zone - Newser
What is the dividend policy of Fennec Pharmaceuticals Inc. stockCapitalize on market momentum for maximum gains - Jammu Links News
What institutional investors are buying Fennec Pharmaceuticals Inc. stockSuperior portfolio returns - Jammu Links News
How does Fennec Pharmaceuticals Inc. compare to its industry peersExceptional profit potential - Jammu Links News
Is Fennec Pharmaceuticals Inc. a good long term investmentDiscover undervalued opportunities early - Jammu Links News
Is it the right time to buy Fennec Pharmaceuticals Inc. stockDiscover undervalued stocks ready to soar - Jammu Links News
What are the technical indicators suggesting about Fennec Pharmaceuticals Inc.Tremendous growth opportunities - Jammu Links News
Does Fennec Pharmaceuticals Inc. stock perform well during market downturnsTrack top-performing stocks effortlessly - Jammu Links News
Should I hold or sell Fennec Pharmaceuticals Inc. stock in 2025Get ahead with breakthrough trading ideas - Jammu Links News
What data driven models say about Fennec Pharmaceuticals Inc.’s futureTrend Confirmation Scanner with Entry Focus - Newser
Published on: 2025-08-01 07:36:16 - metal.it
Fennec Pharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsEarly Entry Ideas with Momentum Potential - Newser
How to track smart money flows in Fennec Pharmaceuticals Inc.Portfolio Allocation Strategy for Stability - Newser
1.02%
3.70%
자본화:
|
볼륨(24시간):